UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report) saw a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 909,100 shares, a growth of 38.5% from the June 15th total of 656,300 shares. Approximately 4.6% of the shares of the company are sold short. Based […]
ARK Investment Management LLC raised its position in UroGen Pharma Ltd. (NASDAQ:URGN – Get Rating) by 37.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 270,746 shares of the company’s stock after acquiring an additional 73,808 shares during […]
Globeflex Capital L P purchased a new stake in shares of UroGen Pharma Ltd. (NASDAQ:URGN – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,279 shares of the company’s stock, valued at approximately $127,000. Globeflex Capital L P […]
Opaleye Management Inc. boosted its position in UroGen Pharma Ltd. (NASDAQ:URGN – Get Rating) by 22.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 488,656 shares of the company’s stock after acquiring an additional 91,156 shares during the period. UroGen Pharma […]
UroGen Pharma Ltd. (NASDAQ:URGN – Get Rating) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 743,700 shares, a growth of 16.3% from the March 31st total of 639,500 shares. Approximately 3.8% of the shares of the company are sold short. Based on […]